investor.sciclone.com
SciClone Pharmaceuticals, Inc. - Investor Relations
Investors & Media. SciClone Pharmaceuticals (NASDAQ: SCLN) is a revenue-generating, China-centric, specialty pharmaceutical company with a substantial international business and a product portfolio of novel therapies for cancer and infectious diseases. The Company is focused on continuing sales growth and. SciClone Corporate Presentation June, 2015. Jul 23, 2015. SciClone Pharmaceuticals To Report Financial Results For The Second Quarter 2015 On August 10th. May 27, 2015. View all releases ».
investor.sciquest.com
Overview | SciQuest
Historic Stock Price Lookup. SciQuest (NASDAQ: SQI) spend management solutions enable procurement, sourcing and financial professionals to focus on strategic decisions that transform business processes. Our feature-rich products and expert services help hundreds of organizations, including leading global companies, drive bottom line results by improving, automating and optimizing their source-to-settle processes. To join the conversation, please visit the SciQuest Blog. Or follow us on Twitter @SciQuest.
investor.scotts.com
ScottsMiracle-Gro - Investor Relations - Investor Relations
Give Back to Gro. Media Images and Logos. Q3 2015 The Scotts Miracle-Gro Company Earnings Conference Call. Tuesday, August 04, 2015. 160;at 9:00 am ET. Q3 2015 The Scotts Miracle-Gro Company Earnings Conference Call. Tuesday, August 4, 2015 . 9:00 am ET . Click here for webcast. Click here to add this event to your calendar. ScottsMiracle-Gro Announces Third Quarter Results; Re-Affirms Full-Year Earnings Outlook. The Scotts Miracle-Gro Company Increases Quarterly Dividend Payment. Scotts Smarter Solutio...
investor.sdchb.com
SDCHB, LLC - Private Moneylending Opportunities
Put Your Money to Work. Learn how you can have your money work for you. Stop working for your money. Simply enter your information in the box below to learn theses groundbreaking high investment strategies that have the potential to change your entire financial future! We value your privacy and would never spam you. Review a quick Overview of the Investment Process:. Have Money to Invest. Considerations for investment: $5,000 – $50,000. You let your money grow for 3 – 6 months. Backed by Real Property.
investor.se
Welcome to Investor - Investor AB
Investor at a Glance. Listed holdings where we are lead owner. Long ownership horizon and value creation from dividends, value appreciation and cash flow. Our wholly-owned subsidiaries, partner-owned investments and other investments. Mölnlycke Health Care. Risk and Risk Management. Investor and Media Services. We have a long-term perspective for all investments. We always act in the best interest of our portfolio companies by fully supporting them in their efforts to create sustainable value. The Boards...
investor.seagen.com
Seattle Genetics, Inc.: Investors & News : Investors & News
Transforming cancer treatment and advancing new therapies through empowered science. Seattle Genetics is a biotechnology company focused on developing and commercializing innovative, empowered antibody-based therapies for the treatment of cancer. We are the industry leader in antibody-drug conjugates (ADCs), a technology designed to. 160;033 (0.73%). 5,596,432,697. 08/07/15 4:00 pm ET. Minimum 20 minute delay. Seattle Genetics Reports Second Quarter 2015 Financial Results. 07/30/15 4:30 pm ET.
investor.seaspine.com
Investors | Investor | SeaSpine
We are a global medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. We have a comprehensive portfolio of orthobiologics and spinal fusion hardware solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine. 160; 0.25. Data as of 08/17/15 4:00 pm ET. Q2 2015 Seaspine Holdings Corp Earnings Conference Call. 160;at 1:30 pm PT. Thursday, August 13, 2015 .
investor.seattlegenetics.com
Seattle Genetics, Inc.: Investors & News : Investors & News
Transforming cancer treatment and advancing new therapies through empowered science. Seattle Genetics is a biotechnology company focused on developing and commercializing innovative, empowered antibody-based therapies for the treatment of cancer. We are the industry leader in antibody-drug conjugates (ADCs), a technology designed to. 160;245 (5.57%). 5,822,044,765. 08/17/15 4:00 pm ET. Minimum 20 minute delay. Seattle Genetics Reports Second Quarter 2015 Financial Results. 07/30/15 4:30 pm ET. Medical I...
investor.sebi.gov.in
:: SEBI Investor | Home ::
Ensure a strong Future. View Financial Education Programs. View articles for various topics. Joint Program with Exchanges/ Depositories/ Trade Bodies. Information to public on complaints. Scheme for conduct of Awareness Programs for Commodities Derivatives. Share and Debenture Holders. Message of the Day. National Strategy for Financial Education. Securities and Exchange Board of India. Reserve Bank of India. Insurance Regulatory and Development Authority. Listed Companies Status - SCORES.
